Eden Research (LON:EDEN) Shares Down 3.3% – Time to Sell?

Eden Research plc (LON:EDEN)’s stock price fell 3.3% during mid-day trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares traded hands during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The stock has a market capitalization of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The business has a 50 day simple moving average of GBX 3.87 and a 200-day simple moving average of GBX 3.95.

Insider Buying and Selling at Eden Research

In other news, insider Alexander John Abrey purchased 540,540 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek purchased 256,000 shares of the business’s stock in a transaction dated Thursday, February 6th. The stock was purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.